Table 2.
Medical & Cancer Characteristics
| Combined | Breast Cancer | Prostate Cancer | Colorectal Cancer | |||||
|---|---|---|---|---|---|---|---|---|
| (N = 288) | (n = 128) | (n = 90) | (n = 70) | |||||
| Months since Diagnosis, mean (SD) | 11.98 | (5.53) | 11.16 | (5.04) | 11.78 | (5.45) | 13.76 | (6.17) |
| Months since Treatment, mean (SD) | 5.00 | (4.38) | 3.92 | (3.68) | 5.17 | (4.57) | 6.64 | (4.78) |
| Cancer Type, % (n) | ||||||||
| Prostate | 31.3 | (90) | 0 | (0) | 100 | (90) | 0 | (0) |
| Breast | 44.4 | (128) | 100 | (128) | 0 | (0) | 0 | (0) |
| Colorectal | 24.3 | (70) | 0 | (0) | 0 | (0) | 100 | (70) |
| Cancer Stage, % (n) | ||||||||
| 0 | 2.1 | (6) | 4.7 | (6) | 0 | (0) | 0 | (0) |
| I | 20.1 | (58) | 33.5 | (43) | 10.0 | (9) | 8.5 | (6) |
| II | 35.4 | (102) | 35.1 | (45) | 42.2 | (38) | 27.1 | (19) |
| III | 25.0 | (72) | 14.0 | (18) | 22.2 | (20) | 48.5 | (34) |
| Missing | 17.3 | (50) | 12.5 | (16) | 25.5 | (23) | 15.7 | (11) |
| Treatment Type, % (n) | ||||||||
| Neoadjuvant Chemotherapy | 16.0 | (46) | 16.4 | (21) | 0 | (0) | 35.7 | (25) |
| Adjuvant Chemotherapy | 31.3 | (90) | 39.8 | (51) | 1.1 | (1) | 54.3 | (38) |
| Radiation Therapy | 56.6 | (163) | 63.3 | (81) | 62.2 | (56) | 37.1 | (26) |
| Hormone Therapy | 46.9 | (135) | 75.8 | (97) | 29.7 | (38) | 0 | (0) |
| Immunotherapy | 7.6 | (22) | 16.4 | (21) | 1.1 | (1) | 0 | (0) |
| Study Site, % (n) | ||||||||
| San Antonio | 59.4 | (171) | 57.8 | (74) | 55.6 | (50) | 67.1 | (47) |
| Chicago | 40.6 | (117) | 42.2 | (54) | 44.4 | (40) | 32.9 | (23) |